Francois Brisebois
Stock Analyst at LifeSci Capital
(3.76)
# 2,002
Out of 4,512 analysts
375
Total ratings
40.7%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics | Reiterated: Buy | $63 | $45.00 | +40.00% | 28 | Jul 15, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $45 | $38.00 | +18.42% | 4 | Jul 14, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $95 | $56.11 | +69.31% | 29 | Jul 13, 2026 | |
| IRD Opus Genetics | Rated: Buy | $10 | $3.58 | +179.33% | 11 | Jul 11, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $24 | $13.27 | +80.86% | 16 | Jul 11, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $731 → $719 | $320.75 | +124.16% | 29 | Jun 30, 2026 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $25 | $3.82 | +554.45% | 7 | Jun 29, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $4.09 | +119.97% | 17 | Jun 25, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $44 | $23.78 | +85.03% | 29 | Jun 24, 2026 | |
| SVRA Savara | Reiterated: Buy | $10 | $5.71 | +75.13% | 31 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.45 | +104.08% | 14 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9799 | - | 27 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $34.85 | n/a | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $18.33 | n/a | 27 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $80 | $33.12 | n/a | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $7.13 | n/a | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.99 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $6.80 | n/a | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.31 | n/a | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.81 | n/a | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.78 | n/a | 11 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $14.25 | n/a | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $7.43 | n/a | 12 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $20 | $1.15 | n/a | 3 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $60 | $2.29 | n/a | 4 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.98 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $100 | $0.00001 | n/a | 2 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.428 | n/a | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $95.92 | n/a | 1 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.5069 | n/a | 1 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.5 → $4 | $1.24 | n/a | 2 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $7.50 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $15 | $0.0001 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $0.249 | n/a | 4 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $1.22 | n/a | 2 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $1.92 | n/a | 1 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.848 | n/a | 1 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $3.11 | n/a | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $0.06 | n/a | 1 | Feb 13, 2018 |
Definium Therapeutics
Jul 15, 2026
Reiterated: Buy
Price Target: $63
Current: $45.00
Upside: +40.00%
MapLight Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $38.00
Upside: +18.42%
Tarsus Pharmaceuticals
Jul 13, 2026
Reiterated: Buy
Price Target: $95
Current: $56.11
Upside: +69.31%
Opus Genetics
Jul 11, 2026
Rated: Buy
Price Target: $10
Current: $3.58
Upside: +179.33%
COMPASS Pathways
Jul 11, 2026
Maintained: Buy
Price Target: $24
Current: $13.27
Upside: +80.86%
Praxis Precision Medicines
Jun 30, 2026
Reiterated: Buy
Price Target: $731 → $719
Current: $320.75
Upside: +124.16%
Larimar Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $25
Current: $3.82
Upside: +554.45%
Aquestive Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $9
Current: $4.09
Upside: +119.97%
Dyne Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: $44
Current: $23.78
Upside: +85.03%
Savara
Jun 9, 2026
Reiterated: Buy
Price Target: $10
Current: $5.71
Upside: +75.13%
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $2.45
Upside: +104.08%
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.9799
Upside: -
Apr 8, 2025
Reiterated: Buy
Price Target: $61
Current: $34.85
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $65
Current: $18.33
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4 → $80
Current: $33.12
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $16
Current: $7.13
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $1.99
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $28 → $30
Current: $6.80
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $11
Current: $6.31
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $9.81
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $6.78
Upside: n/a
Jul 29, 2024
Maintained: Buy
Price Target: $36
Current: $14.25
Upside: n/a
Jul 1, 2024
Reiterated: Buy
Price Target: $6
Current: $7.43
Upside: n/a
Aug 17, 2023
Maintained: Buy
Price Target: $90 → $20
Current: $1.15
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $8 → $60
Current: $2.29
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $5
Current: $1.98
Upside: n/a
Sep 27, 2022
Maintained: Buy
Price Target: $80 → $100
Current: $0.00001
Upside: n/a
Jul 18, 2022
Initiated Coverage: Buy
Price Target: $18
Current: $0.428
Upside: n/a
May 11, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $95.92
Upside: n/a
Feb 4, 2020
Initiated Coverage: Buy
Price Target: $18
Current: $0.5069
Upside: n/a
Sep 10, 2019
Maintained: Buy
Price Target: $8.5 → $4
Current: $1.24
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $68 → $72
Current: $7.50
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $23 → $15
Current: $0.0001
Upside: n/a
Aug 22, 2019
Maintained: Hold
Price Target: $2 → $1
Current: $0.249
Upside: n/a
Jul 29, 2019
Maintained: Hold
Price Target: $1.5 → $1
Current: $1.22
Upside: n/a
Jun 27, 2019
Upgraded: Buy
Price Target: $50
Current: $1.92
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: $11
Current: $0.848
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: $26
Current: $3.11
Upside: n/a
Feb 13, 2018
Maintained: Buy
Price Target: $210
Current: $0.06
Upside: n/a